Limited brain access for leptin in obesity

Pituitary

Volumn 4, Issue 1-2, 2001, Pages 101-110

  Couce, Marta E ^a   Green, Doug ^a   Brunetto, Amy ^a   Lloyd, Ricardo V ^b   Burguera, Bartolome ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Human brain; Hypothalamic nuclei; Leptin receptor; Ob gene; Obesity

Indexed keywords

ANTIOBESITY AGENT; LEPTIN; NEUROPEPTIDE; PEG OB;

ARTICLE; BODY FAT; BODY MASS; BRAIN; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TARGETING; DRUG TRANSPORT; FEMALE; HORMONE ACTION; HORMONE BLOOD LEVEL; HORMONE DEFICIENCY; HORMONE RESISTANCE; HUMAN; LEAN BODY WEIGHT; MALE; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; WEIGHT REDUCTION;

ANIMALS; BRAIN; CARRIER PROTEINS; HUMANS; HYPOTHALAMUS; INTRACELLULAR MEMBRANES; LEPTIN; OBESITY; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION;

EID: 0035681963     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012951214106     Document Type: Article

References (87)

1. Overweight, obesity, and health risk
2. Annual deaths attributable to obesity in the United States
3. Current estimates of the economic cost of obesity in the United States
4. Genetic and environmental contributions to obesity
5. Obesity in the millennium
6. Changes in energy expenditure resulting from altered body weight
7. Leptin: The tale of an obesity gene
8. Neuroendocrine responses to starvation and weight loss
9. Role of set-point theory in regulation of body weight
10. Appetite and the regulation of body composition
11. Positional cloning of the mouse obese gene and its human homologue
12. Identification and expression cloning of a leptin receptor, OB-R
13. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks
14. Leptin and the regulation of body weight in mammals
15. Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice
16. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor
17. Abnormal splicing of the leptin receptor in diabetic mice
18. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
19. Increased obese mRNA expression in omental fat cells from massively obese humans
20. Decreased cerebrospinal-fluid/serum leptin ratio in obesity: A possible mechanism for leptin resistance
21. Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans
22. Physiological response to long-term peripheral and central leptin infusion in lean and obese mice
23. Leptin enters the brain by a saturable system independent of insulin
24. Obesity and the hypothalamus: Novel peptides for new pathways
25. Central administration of leptin inhibits food intake and activates the sympathetic nervous system in rhesus macaques
26. Leptin enters the brain by a saturable system independent of insulin
27. Penetration neurotrophins and cytokines across the blood-brain/blood-spinal cord barrier
28. Impaired transport of leptin across the blood-brain barrier in obesity
29. Obesity is associated with a decreased of leptin transport across the blood brain barrier in rats
30. Persistence of blood-to-brain transport of leptin in obese leptin-deficient and leptin receptor-deficient mice
31. Expression of leptin receptor isoforms in rat brain microvessels
32. OB protein binds specifically to the choroid plexus of mice and rats
33. Autoradiographic localization of leptin binding in the choroid plexus of ob/ob and db/db mice
34. Localization of leptin receptor in the human brain
35. Fate of leptin after intracerebroventricular injection into the mouse brain
36. Partial saturation and regional variation in the blood-to-brain transport of leptin in normal weight mice
37. The long form of the leptin receptor (OB-Rb) is widely expressed in the human brain
38. Peptin receptor (OB-Rb) expression in normal and neoplastic human pituitaries. Regulation of pituitary cell proliferation by leptin
39. Localization of leptin receptor mRNA and the long form splice variant (Ob-Rb) in mouse hypothalamus and adjacent brain regions by in situ hybridization
40. Human blood-brain barrier leptin receptor. Binding and endocytosis in isolated human brain microvessels
41. Leptin receptor and the brain: A tale of body weight
42. Expression of leptin receptor isoforms in rat brain microvessels
43. Expression and localization of the leptin receptor in endocrine and neuroendocrine tissues of the rat
44. Is brain uptake of leptin in vivo saturable and reduced by fasting?
45. Leptin transport at the blood-cerebrospinal fluid barrier using the perfused sheep choroid plexus model
46. A morphometric study on the development of the lateral ventricle choroid plexus, choroid plexus capillaries and ventricular ependyma in the rat
47. The transport of sugars across the perfused choroid plexus of the sheep
48. Distributions of leptin receptor mRNA isoforms in the rat brain
49. Leptin receptor and neuropeptide Y gene expression in the sheep brain
50. Fate of leptin after intracerebroventricular injection into the mouse brain
51. Leptin activation of Stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice
52. Reflections on STAT3, STAT5, and STAT6 as fat STATs
53. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors
54. A family of cytokine-inducible inhibitors of signalling
55. A new protein containing an SH2 domain that inhibits JAK kinases
56. Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling
57. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families
58. Cloning and characterization of novel CIS family genes
59. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling
60. Identification of SOCS-3 as a potential mediator of central leptin resistance
61. Pituitary corticotroph SOCS-3: Novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion
62. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter
63. Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity
64. CSF leptin levels after exogenous administration of recombinant methionyl human leptin
65. Subcellular localization of leptin in non-tumorous and adenomatous human pituitaries: An immuno-ultrastructural study
66. Neuroendocrine regulation and actions of leptin
67. Direct antidiabetic effect of leptin through triglyceride depletion of tissues
68. Leptin modulates the T-cell immune response and reverses starvation-induced immunosupression
69. Serum leptin levels in normal children: Relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage
70. Comparing the hypothalamic and extrahypothalamic actions of endogenous hyperleptinemia
71. Leptin inhibits bone formation through a hypothalamic relay: A central control of bone mass
72. Leptin is a potent stimulator of bone growth in ob/ob mice
73. Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes
74. Leptin reduces ovariectomy-induced bone loss in rats
75. Vertebral postmenopausal bone loss is reduced in overweight women: A longitudinal study in 155 early postmenopausal women
76. Effects of weight and body mass index on bone meineral density in men and women: The Framingham Study
77. Human leptin deficiency caused by a missense mutation: Multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral effects of leptin, and spontaneous correction of leptin-mediated defects
78. Brief report: Effects of recombinant leptin therapy in a child with congenital leptin deficiency
79. Role of serum leptin, insulin, and estrogen levels as potential mediators of the relationship between fat mass and bone mineral density in men versus women
80. Overview: Neurobiology of OB protein leptin
81. Recombinant leptin for weight loss in obese and lean adults: A randomized, controlled, dose-escalation trial
82. Brief report: Effects of recombinant leptin therapy in a child with congenital leptin deficiency
83. Pharmacokinetics of recombinant human methionyl human leptin (rL) and the effect of antibody formation in lean and obese subjects following subcutaneous (sc) dosing
84. A phase I study including pharmacokinetics of polyethylene glycol conjugated interleukin-2
85. Weekly subcutaneous pegylated recombinant native human leptin (PEG-OB) administration in obese men
86. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
87. Signals that regulate food intake and energy homeostasis